Title:
IL-1β SUPPRESSING AGENT
Document Type and Number:
Japanese Patent JP2003192586
Kind Code:
A
Abstract:
To provide an IL-1β suppressing agent effective for lowering the IL-1β level in the blood of a postoperative patient or a patient affected by infectious diseases, scald, etc., and promoting the recovery from these diseases.
The IL-1β suppressing agent contains glutamine and arginine.
Inventors:
KAMIYA HIDEHIKO
HANAOKA YOSHIAKI
HARA HIROSUKE
SUGA ITSUHITO
UMEHARA NORIMITSU
KASAI SHUICHI
HANAOKA YOSHIAKI
HARA HIROSUKE
SUGA ITSUHITO
UMEHARA NORIMITSU
KASAI SHUICHI
Application Number:
JP2001397492A
Publication Date:
July 09, 2003
Filing Date:
December 27, 2001
Export Citation:
Assignee:
SS PHARMACEUTICAL CO
International Classes:
A61K31/355; A61K31/015; A61K31/198; A61K31/202; A61K31/375; A61P7/00; A61P7/02; A61P17/02; A61P19/02; A61P19/06; A61P19/10; A61P29/00; A61P35/00; A61P37/02; A61P43/00; (IPC1-7): A61K31/198; A61K31/015; A61K31/202; A61K31/355; A61K31/375; A61P7/00; A61P7/02; A61P17/02; A61P19/02; A61P19/06; A61P19/10; A61P29/00; A61P35/00; A61P37/02; A61P43/00
Attorney, Agent or Firm:
Miyuki Ariga (6 people outside)
Previous Patent: ORAL COMPOSITION
Next Patent: UV-INDUCED PROSTAGLANDIN E2 PRODUCTION SUPPRESSING AGENT
Next Patent: UV-INDUCED PROSTAGLANDIN E2 PRODUCTION SUPPRESSING AGENT